SK BIOPHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85,900 KRW | +2.87% |
|
+3.87% | -14.44% |
| 30/01 | SK Biopharmaceuticals Swings to Profit in Q4 | MT |
| 2023 | SK Group Advances Net Zero Transition via Key Renewable Energy Deal | MT |
Evolution of the average Target Price on SK Biopharmaceuticals Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
e5.oahfuPD_HuMQ28yyl11a8uIO4shPbGojVC_-GQTP2ck.158b2rXGU4h1mKr2wRg5opM6i4Z7Px1TMlmkV0uouqTv2yzUh7wuu0GdnQ~ddaf6bcb3c7028797506caa2eab541a9
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
83,500
KRW
Average target price
1,06,133
KRW
Spread / Average Target
+27.11%
High Price Target
1,30,000
KRW
Spread / Highest target
+55.69%
Low Price Target
51,000
KRW
Spread / Lowest Target
-38.92%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
A-
EPS Revisions
- Stock Market
- Equities
- A326030 Stock
- Consensus SK Biopharmaceuticals Co., Ltd.
